Biotech Startups
9,990 companies tagged Biotech, with their investors and founders.
Accipiter Biosciences uses computational protein design to develop de novo, single-agent protein therapies that engage multiple cell-surface receptors at once, functioning as agonists. Its platform targets complex conditions such as autoimmune disorders and cancer as an alternative to traditional combination therapies.
0 investors
0 investors
Accu-Break Pharmaceuticals develops patent-pending tablet technologies that let pharmaceutical tablets be swallowed whole or broken into precise half, third, or quarter doses using a pharmacologically inactive break region. Its technologies target drugmakers seeking dose flexibility, product life-cycle management, and extended patent protection.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Achelios Therapeutics develops therapies for chronic pain conditions including temporomandibular joint pain, migraine, and arthritis-related joint pain through repurposed and reformulated drug candidates. The company addresses unmet medical needs in chronic pain that have been underserved by larger pharmaceutical firms.
0 investors
0 investors
Aclipse Therapeutics is a clinical-stage biopharmaceutical company developing disease-modifying drug candidates for life-threatening neuromuscular and severe diseases, using genomic, proteomic, and biomarker data. Its lead programs include M107 for gastroparesis and M102 for amyotrophic lateral sclerosis (ALS).
0 investors
Acomhal Research develops a peptide drug designed to target and eliminate cancer stem cells, preventing tumor recurrence and metastasis across multiple cancer types including glioblastoma, breast cancer, and others. The company operates in the biotech sector, focusing on novel therapeutics for drug-resistant cancers.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Actinium is developing targeted radiotherapy treatments using Actinium-225 and related isotopes for oncology indications including prostate cancer, non-small cell lung cancer, breast cancer, and acute myeloid leukemia. The company's lead candidates include ATNM-400 for solid tumors and Actimab-A for blood malignancies.
0 investors
0 investors
Acuitive Technologies is an orthopedic medical device company developing products using citrate-based biodegradable biomaterials for regenerative applications, including foot and ankle surgery. Its team consists of veterans of the orthopedic industry drawn from companies such as J&J, Zimmer, Stryker, and MAKO.
0 investors
Acurx Pharmaceuticals is a clinical-stage biopharmaceutical company developing a new class of antibiotics targeting bacterial infections classified as priority pathogens by the WHO, CDC, and FDA. It is a publicly held company focused on antibiotic drug development.
0 investors